My watch list  

PainCeptor Pharma

PainCeptor Pharma is a private Canadian company focused on the development of drugs that act outside the central nervous system to treat pain.[1] The company's strategic focus on peripheral rather than central acting therapeutics is an attempt to avoid the known side-effects of existing central acting agents.[2] The primary molecular targets addressed by PainCeptor are members of the ASIC ion channel family and nerve growth factor (NGF) and NGF receptors.[2] Though PainCeptor refers to itself as a biopharmaceutical company on its website,[1] its two primary publicly reported drug discovery projects aim to deliver small molecule therapeutics.[2]


  1. ^ a b PainCeptor Pharma corporate home page (HTML). PainCeptor Pharma public corporate website. Retrieved on 2007-10-18.
  2. ^ a b c Dimond, Patricia F.. "Revamping Drug Discovery Strategies", Drug Discovery, Genetic Engineering News, 2007-10-01. Retrieved on 2007-10-18. 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "PainCeptor_Pharma". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE